Home  

Random  

Nearby  



Log in  



Settings  



Donate  



About Wikipedia  

Disclaimers  



Wikipedia





Methyl-DOB





Article  

Talk  



Language  

Watch  

Edit  





Methyl-DOB, or 4-bromo-2,5-dimethoxy-N-methylamphetamine, is a lesser-known psychedelic drug. It is similar in structure to DOB. Methyl-DOB was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 8 mg, and the effects onset begin after 3 hours and last up to 36 hours. Methyl-DOB produces many physical effects, such as mydriasis and muscle tenseness, but few psychoactive effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of Methyl-DOB.

Methyl-DOB
Names
Preferred IUPAC name

1-(4-Bromo-2,5-dimethoxyphenyl)-N-methylpropan-2-amine

Identifiers

CAS Number

3D model (JSmol)

ChEMBL
ChemSpider

PubChem CID

UNII

CompTox Dashboard (EPA)

  • InChI=1S/C12H18BrNO2/c1-8(14-2)5-9-6-12(16-4)10(13)7-11(9)15-3/h6-8,14H,5H2,1-4H3 checkY

    Key: GURVSGCCXMIFMQ-UHFFFAOYSA-N checkY

  • InChI=1/C12H18BrNO2/c1-8(14-2)5-9-6-12(16-4)10(13)7-11(9)15-3/h6-8,14H,5H2,1-4H3

    Key: GURVSGCCXMIFMQ-UHFFFAOYAZ

  • Brc1cc(OC)c(cc1OC)CC(NC)C

Properties

Chemical formula

C12H18BrNO2
Molar mass 288.181 g/mol

Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

checkY verify (what is checkY☒N ?)

Infobox references

See also

edit
edit


  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Methyl-DOB&oldid=1072437799"
     



    Last edited on 17 February 2022, at 18:59  





    Languages

     


    تۆرکجه
    فارسی
    Српски / srpski
    Srpskohrvatski / српскохрватски
     

    Wikipedia


    This page was last edited on 17 February 2022, at 18:59 (UTC).

    Content is available under CC BY-SA 4.0 unless otherwise noted.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Terms of Use

    Desktop